Your browser doesn't support javascript.
loading
Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: A retrospective cohort study.
Giacomelli, Andrea; Pagani, Gabriele; Ridolfo, Anna L; Oreni, Letizia; Conti, Federico; Pezzati, Laura; Bradanini, Lucia; Casalini, Giacomo; Bassoli, Cinzia; Morena, Valentina; Passerini, Simone; Rizzardini, Giuliano; Cogliati, Chiara; Ceriani, Elisa; Colombo, Riccardo; Rusconi, Stefano; Gervasoni, Cristina; Cattaneo, Dario; Antinori, Spinello; Galli, Massimo.
Afiliación
  • Giacomelli A; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.
  • Pagani G; Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Milan, Italy.
  • Ridolfo AL; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.
  • Oreni L; Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Milan, Italy.
  • Conti F; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.
  • Pezzati L; Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Milan, Italy.
  • Bradanini L; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.
  • Casalini G; Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Milan, Italy.
  • Bassoli C; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.
  • Morena V; Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Milan, Italy.
  • Passerini S; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.
  • Rizzardini G; Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Milan, Italy.
  • Cogliati C; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.
  • Ceriani E; Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Milan, Italy.
  • Colombo R; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.
  • Rusconi S; Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Milan, Italy.
  • Gervasoni C; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.
  • Cattaneo D; Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Milan, Italy.
  • Antinori S; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.
  • Galli M; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.
J Med Virol ; 93(3): 1421-1427, 2021 03.
Article en En | MEDLINE | ID: mdl-32776534

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Ritonavir / Lopinavir / SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 / Hidroxicloroquina Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Ritonavir / Lopinavir / SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 / Hidroxicloroquina Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Año: 2021 Tipo del documento: Article